IDiyas

For the Inventor, By the Inventor

Anaheim, CA, United States of America

Darren L Holmes

USPTO Granted Patents = 16

Average Co-Inventor Count = 4.9

ph-index = 12

Forward Citations = 1,042(Granted Patents)


Location History:

  • Montreal, CA (2001 - 2007)
  • Anaheim, CA (US) (2007 - 2012)

Company Filing History:

goldMedal14 out of 28 
 
Conjuchem, Inc.
 patents
silverMedal2 out of 10 
 
Conjuchem Biotechnologies Inc.
 patents

Years Active: 2001-2012

Loading Chart...
16 patents (USPTO):Explore Patents
1. 8093206 - Methods involving long lasting synthetic exendin-4 peptide conjugates (2012-01-10),
2. 8084414 - Methods involving long lasting synthetic exendin-4-peptide conjugates (2011-12-27),
3. 8080516 - Long lasting synthetic exendin-4 peptide conjugates (2011-12-20),
4. 7256253 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2007-08-14),
5. 7166695 - Affinity markers for human serum albumin (2007-01-23),
6. 6887849 - Long lasting synthetic glucagon-like peptide {GLP-1} (2005-05-03),
7. 6887470 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-05-03),
8. 6849714 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-02-01),
9. 6821949 - Long lasting synthetic glucagon-like peptide (GLP-1) (2004-11-23),
10. 6610825 - Method for alleviating pain or providing an analgesic effect in a patient (2003-08-26),
11. 6602981 - Antinociceptive agent derivative (2003-08-05),
12. 6593295 - Long lasting insulinotropic peptides (2003-07-15),
13. 6514500 - Long lasting synthetic glucagon like peptide {GLP-!} (2003-02-04),
14. 6500918 - Conjugate comprising an antinociceptive agent covalently bonded to a blood component (2002-12-31),
15. 6437092 - Conjugates of opioids and endogenous carriers (2002-08-20),

Title: Darren L Holmes: A Trailblazer in Biotechnology Innovation

Introduction:

Darren L Holmes, based in Anaheim, CA (US), is a prolific inventor with a remarkable track record in the field of biotechnology. With 16 patents to his name, he has made significant contributions to the medical industry, particularly in the treatment of diabetes and related diseases.

Latest Patents:

Holmes' latest patents revolve around methods involving long-lasting synthetic exendin-4 peptide conjugates. These modified insulinotropic peptides are designed to form peptidase-stabilized insulinotropic peptides that can create covalent bonds with blood components to form a conjugate. These innovative peptides are administered for the treatment of diabetes and other associated conditions.

Career Highlights:

Having worked at Conjuchem, Inc. and Conjuchem Biotechnologies Inc., Holmes has gained valuable experience and expertise in the biotechnology sector. His innovative patents have paved the way for advancements in the field, showcasing his dedication to enhancing patient care through pioneering medical solutions.

Collaborations:

Throughout his career, Holmes has collaborated with esteemed professionals such as Dominique P Bridon and Alan M Ezrin. These partnerships have fostered a creative and collaborative environment, leading to the development of groundbreaking technologies and treatments in the realm of biotechnology.

Conclusion:

In conclusion, Darren L Holmes emerges as a beacon of creativity and perseverance in the realm of innovation. His dedication to pushing the boundaries of medical science and developing cutting-edge solutions underscores his legacy as a visionary inventor. Holmes' work continues to inspire future generations of inventors and entrepreneurs, shaping the landscape of biotechnology innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…